Welcome to our dedicated page for Babcock & Wilcox Enterprises I SEC filings (Ticker: BWSN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The BWSN SEC filings page on Stock Titan provides access to regulatory documents for the Babcock & Wilcox Enterprises, Inc. senior notes trading under the symbol BWSN, along with related issuer filings. Babcock & Wilcox Enterprises, Inc. is an Akron, Ohio–based company that describes itself as a leader in energy and environmental products and services for power and industrial markets worldwide. Its filings under the Securities Exchange Act of 1934 offer detailed information about its securities, including senior notes, preferred stock, and common stock.
For BWSN and related note issues, investors can review Form 8-K current reports that discuss material events such as capital-raising transactions, changes in credit facilities, and other significant developments. For example, 8-K filings reference senior notes due 2026 and outline events like an at-the-market equity offering and a new senior secured credit agreement with Axos Bank. These filings help explain how the issuer manages its capital structure and financing arrangements around its notes.
The filings set also includes Form 25 notifications, such as the Form 25 concerning the removal from listing and/or registration of a class of 8.125% Senior Notes due 2026 on the New York Stock Exchange. This type of document is important for understanding listing status and the regulatory steps taken when a class of notes is struck from an exchange.
On Stock Titan, users can view these SEC filings as they are made available through EDGAR and can use AI-powered summaries to interpret key points. That includes context around senior note terms when disclosed, changes in listing status, and how new credit facilities or capital-raising activities may relate to the BWSN notes. The page is a focused entry point for examining the regulatory record of BWSN within the broader disclosure framework of Babcock & Wilcox Enterprises, Inc.
Babcock & Wilcox Enterprises granted 115,000 restricted stock units to Chief Financial Officer Cameron M. Frymyer on 08/07/2025 under the Amended and Restated Long-Term 2021 Incentive Plan. Each RSU represents a contingent right to receive one share of the companys common stock. The grant is exercisable as RSUs that vest in three annual installments beginning August 7, 2026. The Form 4 reports 115,000 derivative securities beneficially owned following the transaction in a direct ownership form and was signed by an attorney-in-fact on 08/11/2025.
John J. Dziewisz, General Counsel & Secretary of Babcock & Wilcox Enterprises, Inc. (BWSN), reported both a small open‑market sale and a large restricted stock unit grant. On 08/07/2025 he sold 2,915 shares of common stock at $1.34 per share pursuant to a Rule 10b5‑1 trading plan, leaving him with 239,381 shares held directly. The filing also reports an award of 115,000 restricted stock units (RSUs) under the company’s Amended and Restated Long‑Term 2021 Incentive Plan; each RSU represents a contingent right to one share.
The RSUs vest in three annual installments beginning on August 7, 2026, which ties the grant to multi‑year retention. The sale was executed under an established trading plan rather than as an ad hoc disposition.
Babcock & Wilcox Enterprises, Inc. furnished a press release announcing its financial results for the quarter ended June 30, 2025 and attached that release as Exhibit 99.1. The company also posted an investor presentation on its investor relations website at www.babcock.com, attached as Exhibit 99.2. The filing states that the information in those exhibits is furnished and expressly not to be treated as "filed" or incorporated by reference in other registrations or reports except by specific reference. No financial figures or analysis are included in this 8-K itself; readers must consult the attached exhibits for details.
Babcock & Wilcox Enterprises, Inc. (BWSN) submitted a Form 144 reporting a proposed sale of 2,915 shares of common stock, with an aggregate market value of $3,906.00, to be sold approximately on 08/08/2025 through Charles Schwab & Co., Inc. on the NYSE. The securities were recorded as acquired on 08/05/2025 by a restricted stock lapse and the filing lists the payment type as equity compensation.
The filing also discloses a recent sale by the same account of 2,551 shares on 07/31/2025 for $2,364.00, and reports total shares outstanding of 98,404,024. The filer signs a representation that they do not possess undisclosed material adverse information about the issuer.